Join the club for FREE to access the whole archive and other member benefits.

Amir Zarrinpar

Gastroenterologist Assistant Professor of Medicine

As the health burden of obesity, type 2 diabetes mellitus, non-alcoholic fatty liver disease (NAFLD) increases, Amir Zarrinpar hopes to perform high-impact research investigating novel therapeutic pathways in these diseases that, as of yet, have few curative options.

He is a physician scientist who performs basic, translational, and clinical research focused on diseases related to metabolism (e.g. metabolic syndrome, obesity, non-alcoholic fatty liver disease, atherosclerosis, and type 2 diabetes. His laboratory investigates the intersection of circadian rhythms, gut signaling, and the microbiome and how the three together can underlie a variety of pathological conditions. By using engineered bacteria and time restricted feeding, we hope to understand how to prevent and treat these conditions. He is also a practicing gastroenterologist at VA San Diego where he directs the bariatric endoscopy clinic and perform research investigating how to use precision medicine to improve weight loss and non-alcoholic liver disease outcomes. Finally, he is a dedicated mentor, striving to help young scientists achieve their career goals. 

Visit website:


See also: Academia UC San Diego School of Medicine - School for medical and scientific training.

Details last updated 16-Aug-2022

Mentioned in this Resource

Amir Zarrinpar News

Employing native bacteria as ideal chassis for therapeutic delivery and cure

UC San Diego School of Medicine - 04-Aug-2022

Re-engineered native bacteria serve as chassis to introduce therapeutics into the gut